Soundmark Wealth Management, LLC Sigilon Therapeutics, Inc. Transaction History

Soundmark Wealth Management, LLC

  • $0
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$2.58 - $6.13 $64,500 - $153,250
-25,000 Reduced 49.45%
25,555 $71,000
Q3 2021

Oct 13, 2021
SELL
$4.42 - $10.61 $22,100 - $53,050
-5,000 Reduced 9.0%
50,555 $286,000
Q2 2021

Jul 13, 2021
BUY
$9.15 - $20.17 $508,328 - $1.12 Million
55,555 New
55,555 $595,000

About Sigilon Therapeutics, Inc.

SGTX Quotes by TradingView
  • Ticker SGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,399,300
  • Description
  • Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...
More about SGTX
Track This Portfolio

Track Soundmark Wealth Management, LLC Portfolio

Follow Soundmark Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soundmark Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soundmark Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email